Antigen-independent suppression of ocular angiogenesis via the Fc receptor
通过 Fc 受体对眼部血管生成进行抗原非依赖性抑制
基本信息
- 批准号:10003425
- 负责人:
- 金额:$ 16.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAffinityAntibodiesAntibody SuppressionAntibody TherapyAntigensBindingBinding ProteinsBiochemicalBiologicalBiological ProcessBiologyBloodBlood VesselsBone MarrowCellsChoroidal NeovascularizationComplement ActivationCorneal NeovascularizationDiseaseDoseEndothelial CellsEventExhibitsFab ImmunoglobulinsFc ReceptorFc domainFutureGoalsGrowthHumanIgG1Immune systemImmunoglobulin GImmunologicsImmunologyLaboratoriesLengthLigationMediatingMedicineMicrogliaModalityModelingMolecularMusOcular PathologyPathway interactionsPharmacologyPhenotypePopulationProcessPropertyProteinsReceptor SignalingRetinalRetinal DiseasesRouteSignal PathwaySignal TransductionStrategic PlanningTherapeuticTherapeutic Monoclonal AntibodiesTherapeutic UsesTransgenic MiceTreatment EfficacyVEGFA geneVascular Endothelial Growth FactorsVascular SystemVision researchWorkadaptive immunityangiogenesisantigen bindingbevacizumabblood vessel developmentcell typeclinical effectcytokinedesignhuman monoclonal antibodieshumanized mouseimmune functionimprovedinnovationinsightmacrophagemouse modelnovelnovel therapeuticsocular angiogenesisprogramsranibizumabtherapeutic candidate
项目摘要
Abstract
Aberrant angiogenesis, a process of new blood vessel formation, is implicated in a variety of
diseases that affect nearly 10% of the world’s population. In new and exciting work, we made the
surprising observation that human IgG1, as a class, suppresses multiple models of ocular and
non-ocular angiogenesis in mice and cells independent of their actual target. This target-
independent angiostatic effect is mediated through FcγRI receptor signaling. Given the
abundance of IgG1 proteins in the blood, as well as their widespread therapeutic use, our findings
assume broad importance in better understanding the full range of the biological effects of
antibodies. The extent and precise mechanisms of IgG/Fc receptor modulation of the vasculature
remain to be deciphered. Therefore, it is critical to define the immunological molecular signaling
pathways responsible for mediating the angioinhibitory effects of human IgG1/FcγRI ligation. It is
also important to delineate the influence of therapeutic FcγRI-binding proteins on the cell types
and molecular pathways involved in aberrant angiogenesis. In addition to advancing the
fundamental biology of IgG/Fc-mediated angiosuppression, our findings may also address a
significant ophthalmic need by improving existing IgG1-containing medicines. To that end, we will
determine whether a rationally guided re-dosing or reformulation of bevacizumab, a full-length
humanized IgG1 antibody, can substantially improve its therapeutic efficacy by exploiting this
newly discovered anti-angiogenic activity, which is separate from VEGFA neutralization. In order
to accomplish these goals, we propose to perform detailed studies in models that better mimic
the human vascular and immune systems. We will utilize mouse (including humanized) models
of corneal and choroidal neovascularization to provide novel functional and molecular insights
into how IgG1/FcγRI signaling contributes to modulation of angiogenesis. Findings from this
project will help illuminate innovative molecular basis of the vasculature that can be targeted in
the multitude of ocular pathologies caused by abnormal vessel growth. As such, this proposal is
aligned with the dual goals of the Retinal Diseases and Immunology Programs of NEI's Vision
Research: Needs, Gaps, and Opportunities Strategic Plan.
摘要
异常血管生成是一种新血管形成的过程,与多种血管生成相关。
这些疾病影响了世界上近10%的人口。在新的和令人兴奋的工作,我们取得了
令人惊讶的观察结果是,人IgG 1作为一类,抑制多种眼和
小鼠和细胞中的非眼部血管生成与其实际靶点无关。这个目标-
通过FcγRI受体信号传导介导独立的血管生成抑制作用。鉴于
我们的研究结果表明,血液中存在大量的IgG 1蛋白,以及它们广泛的治疗用途,
在更好地理解生物学效应的全方位方面具有广泛的重要性,
抗体的IgG/Fc受体调节血管系统的程度和精确机制
还有待破解因此,明确免疫分子信号传导机制至关重要
负责介导人IgG 1/FcγRI连接的血管抑制作用的途径。是
描述治疗性Fcγ RI结合蛋白对细胞类型的影响也很重要,
以及参与异常血管生成的分子途径。除了推进
IgG/Fc介导的血管抑制的基础生物学,我们的研究结果也可能解决一个问题,
通过改进现有的含IgG 1的药物来满足眼科的显著需求。为此,我们将
确定是否合理指导贝伐珠单抗的重新给药或重新配制,全长
人源化IgG 1抗体,可以通过利用这一点显著提高其治疗功效。
新发现的抗血管生成活性,这是从VEGFA中和分离。为了
为了实现这些目标,我们建议在模型中进行详细的研究,
人体血管和免疫系统。我们将利用小鼠(包括人源化)模型
角膜和脉络膜新生血管,以提供新的功能和分子见解
IgG 1/FcγRI信号传导如何促进血管生成的调节。时发现的问题
该项目将有助于阐明血管系统的创新分子基础,
由异常血管生长引起的多种眼部病变。因此,这项建议是
与NEI愿景的视网膜疾病和免疫学计划的双重目标保持一致
研究:需求,差距和机会战略计划。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jayakrishna Ambati其他文献
Jayakrishna Ambati的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jayakrishna Ambati', 18)}}的其他基金
Cytosolic SINE retrotransposable element cDNA and mitochondrial DNA in aging retina
衰老视网膜中的胞质 SINE 逆转录转座元件 cDNA 和线粒体 DNA
- 批准号:
10722062 - 财政年份:2023
- 资助金额:
$ 16.15万 - 项目类别:
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
定义 SINE 逆转录转座子和炎症小体激活在阿尔茨海默病中的作用
- 批准号:
10696066 - 财政年份:2022
- 资助金额:
$ 16.15万 - 项目类别:
Defining the role of SINE retrotransposons and inflammasome activation in Alzheimer's disease
定义 SINE 逆转录转座子和炎症小体激活在阿尔茨海默病中的作用
- 批准号:
10517678 - 财政年份:2022
- 资助金额:
$ 16.15万 - 项目类别:
Nlrp3 inflammasome activation in early diabetic retinopathy - Administrative Supplement ERG Request
早期糖尿病视网膜病变中 Nlrp3 炎症小体激活 - 行政补充 ERG 请求
- 批准号:
10643583 - 财政年份:2020
- 资助金额:
$ 16.15万 - 项目类别:
Inflammasome-based Alzheimer's disease therapy in the context of diabetes
糖尿病背景下基于炎症小体的阿尔茨海默病治疗
- 批准号:
10287353 - 财政年份:2020
- 资助金额:
$ 16.15万 - 项目类别:
Nlrp3 inflammasome activation in early diabetic retinopathy
早期糖尿病视网膜病变中 Nlrp3 炎性体激活
- 批准号:
10414049 - 财政年份:2020
- 资助金额:
$ 16.15万 - 项目类别:
Nlrp3 inflammasome activation in early diabetic retinopathy
早期糖尿病视网膜病变中 Nlrp3 炎性体激活
- 批准号:
10626060 - 财政年份:2020
- 资助金额:
$ 16.15万 - 项目类别:
Visual system and cognitive biology in normal animals versus in an animal model of Alzheimer's disease with or without diabetes treated with solo or dual inflammasome inhibitors
正常动物的视觉系统和认知生物学与单独或双重炎性体抑制剂治疗的患有或不患有糖尿病的阿尔茨海默病动物模型的比较
- 批准号:
10712956 - 财政年份:2020
- 资助金额:
$ 16.15万 - 项目类别:
Non-canonical inflammasome in activation in RPE degeneration
RPE 变性中激活的非典型炎症小体
- 批准号:
10338080 - 财政年份:2019
- 资助金额:
$ 16.15万 - 项目类别:
Antigen-independent suppression of ocular angiogenesis via the Fc receptor
通过 Fc 受体对眼部血管生成进行抗原非依赖性抑制
- 批准号:
9765313 - 财政年份:2018
- 资助金额:
$ 16.15万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 16.15万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 16.15万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 16.15万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 16.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists